A non-bioabsorbable tubular device intended to be implanted in a peripheral artery (excludes aorta, coronary, pulmonary, and intracranial arteries) to indefinitely maintain patency and improve luminal diameter in patients with atherosclerotic disease, or follo
| Company | Devices | Share |
|---|---|---|
| Abbott Vascular Inc. | 198 | 15% |
| Biotronik Ag | 187 | 14% |
| Covidien Lp | 182 | 14% |
| Cook Ireland Ltd | 179 | 14% |
| Bard Peripheral Vascular, Inc. | 146 | 11% |
| Ev3, Inc | 102 | 8% |
| Boston Scientific Corporation | 96 | 7% |
| Cordis Us Corp. | 67 | 5% |
| Medtronic, Inc. | 35 | 3% |
| Terumo Corporation | 32 | 2% |
| Veryan Medical Limited | 29 | 2% |
| Cook Incorporated | 24 | 2% |
Company = labeler of record on GUDID. 14 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| NIP | STENT, SUPERFICIAL FEMORAL ARTERY | 860 |
| NIO | STENT, ILIAC | 480 |
| FGE | CATHETER, BILIARY, DIAGNOSTIC | 119 |
| FGE | Stents, drains and dilators for the biliary ducts | 110 |
| NIN | STENT, RENAL | 96 |
| NIP | Stent, Superficial Femoral Artery | 78 |
Use these as the dimensions to specify in a tender line.
1,290 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Peripheral artery stent, bare-metal", from 14 companies. The largest labeler is Abbott Vascular Inc. with 15% of records.
NIP (STENT, SUPERFICIAL FEMORAL ARTERY), NIO (STENT, ILIAC), FGE (CATHETER, BILIARY, DIAGNOSTIC), FGE (Stents, drains and dilators for the biliary ducts)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add peripheral artery stent, bare-metal to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.